68
Views
2
CrossRef citations to date
0
Altmetric
Article

The use of transrectal ultrasound-guided biopsy following the introduction of prostate-specific antigen testing in Denmark: a population-based analysis

, ORCID Icon, , , , & show all
Pages 169-173 | Received 17 Jul 2017, Accepted 20 Feb 2018, Published online: 08 Mar 2018

References

  • NORDCAN: Nordic Cancer Registry. [cited 2017 May 16]. Available from: http://www.ancr.nu/
  • Wong MC, Goggins WB, Wang HH, et al. Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries. Eur Urol. 2016;70:862–874.
  • Schröder FH, van den Bergh RCN, Wolters T, et al. Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies. Eur Urol. 2010;57:256–266.
  • Lewicki P, Shoag J, Golombos DM, et al. Prognostic significance of a negative prostate biopsy: an analysis of subjects enrolled in a prostate cancer screening trial. J Urol. 2017;197:1014–1019.
  • Klemann N, Røder MA, Helgstrand JT, et al. Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study. Lancet Oncol. 2017;18:221–229.
  • Helgstrand JT, Klemann N, Røder MA, et al. Danish Prostate Cancer Registry (DaPCaR): methodology and early results from a novel national database. CLEP. 2016;8:351–360.
  • Epstein JI, Allsbrook WC, Amin MB, et al. ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005;29:1228–1242.
  • Ducg’s Nationale Retningslinier For Diagnostik Og Behandling Af Prostatacancer [Internet]. 2017. Available from: http://ducg.dk/fileadmin/www.ducg.dk/Prostatacancer/Kl._retningslinjer/2016/5.1._Screening-MB.pdf
  • Grönberg H, Adolfsson J, Aly M, et al. Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study. Lancet Oncol. 2015;16:1667–1676.
  • Fütterer JJ, Briganti A, De Visschere P, et al. Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol. 2015;68:1045–1053.
  • Ohmann EL, Loeb S, Robinson D, et al. Nationwide, population-based study of prostate cancer stage migration between and within clinical risk categories. Scand J Urol. 2014;48:426–435.
  • Thomsen FB, Folkvaljon Y, Brasso K, et al. Prognostic implications of 2005 Gleason grade modification. Population-based study of biochemical recurrence following radical prostatectomy. J Surg Oncol. 2016;114:664–670.
  • Danneman D, Drevin L, Robinson D, et al. Gleason inflation 1998-2011: a registry study of 97,168 men. BJU Int. 2015;115:248–255.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.